Lars H Lund Selected Research

Heart Failure

12/2022	Digoxin use in contemporary heart failure with reduced ejection fraction: an analysis from the Swedish Heart Failure Registry.
1/2022	Utilization of sacubitril/valsartan in patients with heart failure with reduced ejection fraction: real-world data from the ARIADNE registry.
1/2022	Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality.
1/2022	Cardiac resynchronization therapy with or without defibrillator in patients with heart failure.
1/2022	Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial.
1/2022	Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry.
1/2022	Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology.
1/2022	Cardiovascular effects of non-insulin glucose-lowering agents: a comprehensive review of trial evidence and potential cardioprotective mechanisms.
1/2022	Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata.
1/2022	Patiromer for the management of hyperkalaemia in patients receiving renin-angiotensin-aldosterone system inhibitors for heart failure: design and rationale of the DIAMOND trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars H Lund Research Topics

Disease

147	Heart Failure 12/2022 - 12/2003
17	Atrial Fibrillation 12/2022 - 08/2014
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 10/2016
9	Inflammation (Inflammations) 01/2021 - 02/2017
8	Hypertension (High Blood Pressure) 01/2022 - 09/2013
8	Pulmonary Hypertension 09/2021 - 08/2014
6	Stroke (Strokes) 01/2022 - 01/2015
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2019
5	Diabetes Mellitus 01/2021 - 01/2015
5	Heart Diseases (Heart Disease) 01/2021 - 01/2016
5	Chronic Renal Insufficiency 01/2021 - 01/2018
4	Infections 01/2022 - 04/2004
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2015
4	Obesity 01/2021 - 01/2006
4	Hyperkalemia 04/2020 - 07/2017
4	Hemorrhage 01/2020 - 10/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2022 - 03/2015
3	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022 - 01/2015
3	Myocardial Infarction 01/2022 - 10/2016
3	Coronary Artery Disease (Coronary Atherosclerosis) 11/2021 - 02/2007
3	COVID-19 11/2021 - 01/2021
3	Acute Coronary Syndrome 01/2021 - 01/2015
3	Anemia 01/2020 - 05/2016
3	Cardiogenic Shock 02/2019 - 11/2018
3	Cardiomyopathies (Cardiomyopathy) 01/2019 - 11/2011
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022 - 02/2017
2	Frailty 11/2021 - 01/2018
2	Left Ventricular Dysfunction 03/2021 - 01/2021
2	Cardiac Arrhythmias (Arrythmia) 01/2021 - 03/2010
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2019
2	Hypotension (Low Blood Pressure) 01/2021 - 11/2019
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2020 - 01/2018
2	Kidney Diseases (Kidney Disease) 01/2019 - 07/2017
2	Sepsis (Septicemia) 01/2019 - 01/2018
2	Neoplasms (Cancer) 01/2018 - 01/2015
2	Bundle-Branch Block (Fascicular Block) 03/2015 - 10/2014
2	Cachexia 08/2009 - 05/2009
2	Weight Gain 08/2009 - 01/2006
1	Aortic Valve Insufficiency (Aortic Regurgitation) 12/2022

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
13	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2016
13	CreatinineIBA 01/2021 - 08/2014
11	Natriuretic PeptidesIBA 01/2022 - 01/2017
11	SodiumIBA 01/2021 - 03/2005
11	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 09/2013
9	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021 - 02/2014
8	Angiotensin Receptor AntagonistsIBA 01/2022 - 01/2011
8	DiureticsIBA 01/2022 - 01/2018
8	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 11/2015
8	PotassiumIBA 04/2020 - 09/2014
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2016
7	Mineralocorticoid Receptor AntagonistsIBA 01/2021 - 03/2013
6	paragonIBA 01/2022 - 01/2018
5	empagliflozinIBA 01/2022 - 12/2019
5	Neprilysin (Neutral Endopeptidase)IBA 01/2022 - 01/2018
5	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2022 - 09/2015
4	Pharmaceutical PreparationsIBA 12/2022 - 01/2016
4	Valsartan (Vals)FDA Link 01/2022 - 01/2018
4	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2013
4	Hemoglobins (Hemoglobin)IBA 01/2020 - 05/2016
3	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 05/2021 - 01/2020
3	SymportersIBA 01/2021 - 11/2020
3	AnticoagulantsIBA 12/2019 - 11/2016
3	cytidylyl-(3'-5')-cytidine (CpC)IBA 08/2019 - 08/2016
3	Spironolactone (Aldactone)FDA LinkGeneric 10/2018 - 03/2013
3	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 08/2014
3	candesartanIBA 01/2018 - 01/2011
3	Hormones (Hormone)IBA 02/2017 - 12/2014
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2015 - 01/2015
2	Digoxin (Digitek)FDA LinkGeneric 12/2022 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2018
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022 - 01/2021
2	dapagliflozinIBA 01/2022 - 11/2020
2	ReninIBA 01/2021 - 09/2015
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 02/2016
2	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2021 - 01/2021
2	Insulin (Novolin)FDA Link 12/2020 - 01/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 02/2019 - 11/2018
2	Simendan (Levosimendan)IBA 01/2018 - 07/2014
2	ORALIT (ORS)IBA 01/2018 - 04/2015
2	GhrelinIBA 12/2014 - 08/2009
2	Losartan (Cozaar)FDA LinkGeneric 07/2012 - 01/2011
1	patiromerIBA 01/2022
1	Rosiglitazone (Avandia)FDA Link 01/2022
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2022

Therapy/Procedure

46	Therapeutics 02/2022 - 12/2003
23	Heart Transplantation (Grafting, Heart) 01/2022 - 12/2003
14	Cardiac Resynchronization Therapy 01/2022 - 08/2012
11	Heart-Assist Devices 12/2022 - 11/2011
8	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 06/2013
4	Extracorporeal Membrane Oxygenation 03/2021 - 03/2010
3	Drug Therapy (Chemotherapy) 01/2021 - 11/2019
3	Transplantation 11/2018 - 11/2011
2	Defibrillators (Defibrillator) 01/2022 - 05/2017
2	Contraindications 04/2020 - 10/2014
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2019 - 01/2016
2	Lung Transplantation 01/2018 - 01/2018
2	Percutaneous Coronary Intervention 12/2017 - 01/2015
2	Spinal Cord Stimulation 05/2017 - 01/2017